These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 375209)

  • 21. [Action mechanism and clinical indications for thrombocyte aggregation inhibitors].
    Oelz O
    Schweiz Med Wochenschr; 1979 Mar; 109(10):348-53. PubMed ID: 424707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Secondary prevention of ischemic heart disease. Evaluation of platelet function in patients treated with anticoagulants and cod liver oil].
    Głab-Kordecka E
    Pol Arch Med Wewn; 1986 Jan; 75(1):3-12. PubMed ID: 3523447
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of 1-methyl-2-mercapto-5-(3-pyridyl)-imidazole (KC-6141) on rabbit platelet aggregation in vitro and rat platelet retention.
    Umetsu T; Kato T
    Thromb Haemost; 1978 Feb; 39(1):167-76. PubMed ID: 580491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Critical evaluation of the usefulness of drugs inhibiting platelet function in the prevention of postoperative deep venous thrombosis and in ischemic cardiopathy].
    Verstraete M
    Recenti Prog Med; 1980 Apr; 68(4):361-81. PubMed ID: 6992244
    [No Abstract]   [Full Text] [Related]  

  • 25. Spontaneous platelet aggregation in arterial insufficiency: mechanisms and implications.
    Wu KK; Hoak JC
    Thromb Haemost; 1976 Jun; 35(3):702-11. PubMed ID: 989974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is the antithrombotic activity of "antiplatelet" drugs based on protection of endothelium?
    Hladovec J
    Thromb Haemost; 1979 Jun; 41(4):474-8. PubMed ID: 483235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting the inflammatory response in secondary stroke prevention: a role for combining aspirin and extended-release dipyridamole.
    Weyrich AS; Skalabrin EJ; Kraiss LW
    Am J Ther; 2009; 16(2):164-70. PubMed ID: 19300042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of aspirin and dipyridamole and its derivatives on platelet disaggregation.
    Morris CD; Heslop PA
    Cent Afr J Med; 1977 Nov; 23(11):251-3. PubMed ID: 603896
    [No Abstract]   [Full Text] [Related]  

  • 29. [Platelet antiaggregants and arteriopathies].
    Cristol R
    J Mal Vasc; 1981; 6(3):237-41. PubMed ID: 7026714
    [No Abstract]   [Full Text] [Related]  

  • 30. [Prophylaxis of thrombogenesis in the diabetic patient].
    Zurro Hernández J; Arribas Castrillo JM; Durán García S; Quintero de Juana A; Romero E
    Rev Clin Esp; 1974 Sep; 134(5):473-7. PubMed ID: 4438743
    [No Abstract]   [Full Text] [Related]  

  • 31. [Blood platelet aggregation inhibitors in the treatment of heart diseases].
    Verheugt FW
    Ned Tijdschr Geneeskd; 1993 Aug; 137(33):1647-50. PubMed ID: 8371794
    [No Abstract]   [Full Text] [Related]  

  • 32. [Blood platelet function in patients with coronary disease after administration of acetylsalicylic acid and dipyridamole].
    Olszańska-Skorek T; Mazurowa A; Pełczyńska I; Chojnowski K; Hołub A; Drzewoski J
    Pol Tyg Lek; 1983 Feb; 38(9):269-72. PubMed ID: 6866846
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of aspirin and clofibrate on the metabolism and hemostatic functions of blood platelets].
    Stachecki B; Kotelba-Witkowska B; Chmiel J; Olszewska K; Malanowicz W; Górecka R
    Acta Haematol Pol; 1982; 13(3-4):103-17. PubMed ID: 7184294
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical pharmacology of anti-aggregating substances.
    Vermylen J
    Acta Clin Belg; 1975; 30(3):204-9. PubMed ID: 1231459
    [No Abstract]   [Full Text] [Related]  

  • 35. [In vivo platelet aggregation in coronary disease and following administration of various drugs].
    Stolarska B; Skarzyńska M
    Pol Tyg Lek; 1977 Nov; 32(47):1829-31. PubMed ID: 600841
    [No Abstract]   [Full Text] [Related]  

  • 36. [Platelet aggregation inhibitors and anticoagulant therapy].
    Reuter H
    Hippokrates; 1976 Feb; 47(1):75-7. PubMed ID: 955950
    [No Abstract]   [Full Text] [Related]  

  • 37. [Platelet aggregation inhibitors. Their possible use in pediatric pathology].
    Zannino L; Salvadori G
    Minerva Pediatr; 1979 Jan; 31(2):153-69. PubMed ID: 379581
    [No Abstract]   [Full Text] [Related]  

  • 38. [A contribution to the study of blood platelet aggregation].
    Pstruzinová H; Goderová Z; Kristan M
    Cas Lek Cesk; 1982 Nov; 121(47):1462-5. PubMed ID: 7151112
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect on various platelet parameters of dipyridamole (225 mg/day) acetylsalicylic acid (150 mg/day) and their combination in healthy volunteers].
    Aguilar Muñoz A; de la Cruz Cortés JP; Martos Crespo F; de Pablo Molina J; Sánchez de la Cuesta F
    Med Clin (Barc); 1985 Nov; 85(18):743-5. PubMed ID: 4094486
    [No Abstract]   [Full Text] [Related]  

  • 40. Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
    Polli EE; Cortellaro M
    Haematologica; 1980 Jun; 65(3):361-9. PubMed ID: 6778788
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.